Upgrades Neutral Overweight X

ZBH Zimmer Biomet

JP Morgan

$125 $128

Initiated Peer Perform X

ZBH Zimmer Biomet

Wolfe Research

Downgrades Overweight Neutral X

ZBH Zimmer Biomet

Piper Sandler

$140 $115

Initiated Neutral X

ZBH Zimmer Biomet

Goldman

$129

Upgrades Hold Buy X

ZBH Zimmer Biomet

Argus

$150

Downgrades Outperform In-line X

ZBH Zimmer Biomet

Evercore ISI

$135 $125

Initiated Neutral X

ZBH Zimmer Biomet

ROTH MKM

$120

Upgrades Neutral Buy X

ZBH Zimmer Biomet

BTIG Research

$139

Upgrades Underperform Neutral X

ZBH Zimmer Biomet

BofA Securities

Upgrades In-line Outperform X

ZBH Zimmer Biomet

Evercore ISI

$135 $148

Upgrades Underperform Hold X

ZBH Zimmer Biomet

Jefferies

$115 $130

Initiated Sell X

ZBH Zimmer Biomet

UBS

$112

Upgrades Neutral Overweight X

ZBH Zimmer Biomet

Piper Sandler

$135 $145

Upgrades Sec Perform Outperform X

ZBH Zimmer Biomet

RBC Capital Mkts

$125 $141

Upgrades Mkt Perform Outperform X

ZBH Zimmer Biomet

Raymond James

$144

Downgrades Outperform In-line X

ZBH Zimmer Biomet

Evercore ISI

$130

Initiated Underweight X

ZBH Zimmer Biomet

Barclays

$104

Initiated Underperform X

ZBH Zimmer Biomet

Jefferies

$95

Downgrades Buy Hold X

ZBH Zimmer Biomet

Needham

Downgrades Buy Hold X

ZBH Zimmer Biomet

Truist

$128 $142

Downgrades Buy Neutral X

ZBH Zimmer Biomet

Citigroup

$125.15 $135

Downgrades Buy Hold X

ZBH Zimmer Biomet

Canaccord Genuity

$165 $125

Reiterated Buy X

ZBH Zimmer Biomet

Citigroup

$150 $129

Reiterated Hold X

ZBH Zimmer Biomet

Deutsche Bank

$140 $121

Reiterated Mkt Outperform X

ZBH Zimmer Biomet

JMP Securities

$175 $145

Reiterated Neutral X

ZBH Zimmer Biomet

JP Morgan

$150 $114

Reiterated Sector Perform X

ZBH Zimmer Biomet

RBC Capital Mkts

$140 $125

Reiterated Buy X

ZBH Zimmer Biomet

Stifel

$178 $130

Reiterated Buy X

ZBH Zimmer Biomet

Truist

$145 $128

Reiterated Neutral X

ZBH Zimmer Biomet

UBS

$130 $121

Reiterated Underweight X

ZBH Zimmer Biomet

Wells Fargo

$124 $111

Downgrades Buy Neutral X

ZBH Zimmer Biomet

UBS

$172 $130

Downgrades Eq Weight Underweight X

ZBH Zimmer Biomet

Wells Fargo

$170 $124

Downgrades Buy Neutral X

ZBH Zimmer Biomet

Mizuho

Downgrades Overweight Eq-Weight X

ZBH Zimmer Biomet

Morgan Stanley

$165 $145

Downgrades Overweight Neutral X

ZBH Zimmer Biomet

Piper Sandler

$185 $135

Initiated Sector Perform X

ZBH Zimmer Biomet

RBC Capital Mkts

$140

Downgrades Strong Buy Buy X

ZBH Zimmer Biomet

Needham

$175 $158

Initiated Buy X

ZBH Zimmer Biomet

Loop Capital

$165

Initiated Overweight X

ZBH Zimmer Biomet

Barclays

$210

Upgrades Mkt Perform Outperform X

ZBH Zimmer Biomet

Northland Capital

$165 $2300

Upgrades In-line Outperform X

ZBH Zimmer Biomet

Evercore ISI

$175

Upgrades Hold Buy X

ZBH Zimmer Biomet

Argus

$160

Upgrades Underweight Eq Weight X

ZBH Zimmer Biomet

Barclays

$117 $140

Upgrades Neutral Outperform X

ZBH Zimmer Biomet

Robert W. Baird

$132 $154

Upgrades Underperform Mkt Perform X

ZBH Zimmer Biomet

Bernstein

Upgrades Buy Strong Buy X

ZBH Zimmer Biomet

Needham

$146 $155

Upgrades In-line Outperform X

ZBH Zimmer Biomet

Evercore ISI

Upgrades Neutral Buy X

ZBH Zimmer Biomet

Citigroup

Downgrades Overweight Neutral X

ZBH Zimmer Biomet

JP Morgan

Initiated Buy X

ZBH Zimmer Biomet

UBS

$140

Initiated Underweight X

ZBH Zimmer Biomet

Barclays

$131

Initiated Neutral X

ZBH Zimmer Biomet

BTIG Research

Downgrades Strong Buy Buy X

ZBH Zimmer Biomet

Needham

$150

Reiterated Strong Buy X

ZBH Zimmer Biomet

Needham

$146 $150

Initiated Underperform X

ZBH Zimmer Biomet

Bernstein

$96

Downgrades Buy Hold X

ZBH Zimmer Biomet

Argus

Reiterated Strong Buy X

ZBH Zimmer Biomet

Needham

$155 $146

Initiated Outperform X

ZBH Zimmer Biomet

Raymond James

Reiterated Strong Buy X

ZBH Zimmer Biomet

Needham

$144 $155

Upgrades Hold Buy X

ZBH Zimmer Biomet

Stifel

$120 $168

Reiterated Strong Buy X

ZBH Zimmer Biomet

Needham

$144 $155

ZBH  Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.